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ENDOMETRIOSIS: AN INVESTIGATION INTO PERSISTENT PELVIC PAIN 
ELENA MARTEL 
ABSTRACT 
 Objectives: This study aims to explore the relationship between central pain 
amplification and persistent pelvic pain. No previous studies have utilized bimanual 
pelvic examination findings, in addition to pressure-pain analysis, in an effort to 
investigate the mechanisms contributing to Chronic Pelvic Pain (CPP) in women with 
endometriosis.  
Methods: Participants included 144 women aged 18-50 years old, diagnosed with CPP 
and/or surgically-confirmed endometriosis compared to healthy controls. Participants 
were categorized into four groups, including pain-free endometriosis (Endo Ø Pain), 
painful endometriosis (Endo + Pain), Chronic Pelvic Pain without endometriosis (CPP Ø 
Endo), and healthy controls. Pressure-pain Quantitative Sensory Testing (QST) was 
conducted on all participants to determine levels of pain thresholds. External systemic 
tenderpoints were assessed utilizing standardized fibromyalgia tenderpoint criteria. A 
pelvic examination was performed on participants in the gynecological sample in order to 
assess internal tenderness. One-way ANOVA, chi-square analyses were conducted to 
assess descriptive variables. Correlation calculations were performed to assess the 
relationship between pressure-pain thresholds and tenderpoints. Generalized Linear 
Models (GLM) were conducted to analyze the differences on pressure-pain thresholds 
and pelvic exam tenderpoints between groups, while controlling for age and number of 
comorbid chronic pain syndromes (CPS).  
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Results: Endo Ø Pain had a significantly higher stage of endometriosis and were 
significantly older than the Endo + Pain group. Healthy controls had less external 
systemic tenderpoints than all patient subgroups. CPP Ø Endo and Endo + Pain had more 
CPS than healthy controls and Endo Ø Pain. Pelvic exam tenderpoints (r= -0.31, p < 
0.01) and systemic external tenderpoints (r = -0.35, p <0.01) were negatively correlated 
with low pressure-pain threshold. Systemic external tenderpoints were negatively 
correlated with the high pressure staircase (r= -0.41, p < 0.01), but pelvic exam 
tenderpoints were not. The GLMs conducted revealed that Endo Ø Pain had significantly 
higher low pressure-pain threshold compared to both Endo + Pain (difference = 0.57, p < 
0.01, CI= 0.12, 1.02) and healthy controls (difference = 0.55, p < 0.05, CI= 0.08, 1.02). 
The CPP Ø Endo group had significantly lower high pressure-pain threshold scores 
compared to healthy controls (difference = 0.38, p < 0.05, CI= 0.05, 0.71). The Endo + 
Pain group also had significantly lower high-pain thresholds as compared to healthy 
controls (difference= 0.31, p < 0.05, CI= 0.04, 0.58). CPP Ø Endo group had 
significantly more pelvic tenderpoints compared to Endo Ø Pain (difference = 2.81, p < 
0.001, CI = 1.36, 4.27); Endo + Pain group also had significantly more pelvic exam 
tenderpoints than the Endo Ø Pain (difference= 2.10, p < 0.001, CI = 0.96, 3.24). 
Conclusions: The findings of this study suggest that pain thresholds, as measured by 
QST pressure-pain testing, are associated with persistent pelvic pain. CPP Ø Endo and 
Endo + Pain experienced more systemic tenderness, and more CPS than the Endo Ø Pain 
group and healthy controls. This indicates that chronic pain, not endometrial lesions, are 
likely responsible for the development of centralized pain amplification. Although the 
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etiology of endometriosis and CPP is poorly understood, the findings of this study 
contribute to the idea that central sensitization is associated with the shared underlying 
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Endometriosis is a chronic inflammatory condition affecting 6-10% of the female 
population globally (Bulletti, Coccia, Battistoni, & Borini, 2010) . Defined as the 
existence of endometrial glands and stroma outside of the uterus, the diagnosis is 
accompanied by various side effects, including dysmenorrhea, infertility, dyspareunia, 
and pelvic pain. The etiology of the disease is unknown, although it is believed to be a 
multifactorial illness with both epigenetic and environmental influences (Johnson, 
Hummelshoj, & World Endometriosis Society Montpellier Consortium, 2013). Evidence 
has shown risk factors related to gynecologic history, family history, nutrition, alcohol 
use, embryonic factors and race (Riazi et al., 2015). Endometriosis may increase a 
woman’s risk of cancer or autoimmune disorders (Surrey et al., 2017). 
In cases of endometriosis, ectopic endometrial tissue can appear throughout the 
body, causing inflammatory reactions and subsequent pain. The discovery of Circulating 
Endometrial Cells (CECs) in the peripheral blood of endometrial patients sheds light on 
the origin of these distant metastases. The invasiveness of these cells leads to recurrence, 
widespread circulation, and lesion presence in organs such as the lungs (Chen et al., 
2017). While endometrial lesions are most common in pelvic organs and the ovaries, 
extrapelvic lesions have also been reported. More commonly, the gastrointestinal and 
genitourinary systems are involved, as well as the lungs, diaphragm and breast. In rare 
cases, endometrial lesions have been discovered in the brain. A 2004 case report by 
Sarma et al. described the pathological diagnosis of cerebellar endometriosis, and the 
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accompanying side effects of the central nervous system involvement (Sarma et al., 
2004). On MRI, the endometrioma in the brain phenotypically resembled that found in 
the pelvis in the more common endometriosis patient.  
Although the disease typically presents in adolescence, diagnosis often occurs 
after years of persistent pelvic pain. Endometriosis is typically identified in women of 
reproductive age, however, cases of pre-menarcheal diagnoses have been reported (Marc 
R. Laufer, Sanfilippo, & Rose, 2003). Even so, the age of menarche is a variable 
influencing the onset of the disease. Treloar et al. reported that menarche prior to age 14 
strongly correlates with endometriosis. There is an increased risk of developing 
endometriosis in those with both an earlier age of menarche and onset of dysmenorrhea 
(Treloar, Bell, Nagle, Purdie, & Green, 2010). Endometriosis is laparoscopically 
diagnosed in 67% of adolescent girls reporting Chronic Pelvic Pain (CPP), but resistant to 
standard clinical treatments such as non-steroidal anti-inflammatory drugs (NSAIDs) or 
oral contraceptive pills (OCPs) (M. R. Laufer, Goitein, Bush, Cramer, & Emans, 1997). 
The majority of adult patients experience cyclic pelvic pain, while adolescents with 
endometriosis report acyclic CPP (Dessole, Melis, & Angioni, 2012). 
During surgical confirmation of endometriosis, the disease state is staged 
according to standards set by the American Society of Reproductive Medicine. Peritoneal 
and ovarian lesions are categorized as red (including red, pink, and clear lesions), white 
(including white and yellow/brown lesions), and black (including black and blue lesions). 
In addition to lesion color, depth of tissue implantation (centimeters) is also assessed. 
Adhesions are categorized as filmy or dense in addition to other pathological findings. 
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Stage I of the disease is considered “minimal”, Stage II is “mild”, Stage III is “moderate”, 
Stage IV and V are “severe”. As the severity of the stages increases, so does the 
implantation depth. Staging is determined based on a weighted point system as the pelvic 
region is assessed for number, size, and location of endometrial lesions. The presence of 
disease in other regions outside of the pelvis, including the bowel and urinary tract, are 
also considered (“Revised American Society for Reproductive Medicine classification of 
endometriosis,” 1997).  
 
Figure 1: Guidelines for Operative Endometriosis Staging  





Endometriosis can be classified into three generalized categories based on 
physical presentation. Deeply infiltrating endometriosis (DIE), the most aggressive 
presentation of the disease, can be distinguished from peritoneal endometriosis and 
endometriotic ovarian cysts (Laganà et al., 2017). The lesions must infiltrate >5mm of 
tissue in order to meet clinical criteria for DIE categorization. An operative report by 
Chopin et al. found that surgical excision of DIE lesions successfully alleviated pain 
symptoms post-operatively (Chopin et al., 2005).  
The symptoms of endometriosis, including pain, fatigue, infertility, and 
gastrointestinal problems, vary with disease severity. As previously reported with 
patients, the severity of symptoms does not positively correlate with advanced stages. A 
patient with Stage I endometriosis could experience higher pain levels and increased 
symptoms compared to those with more advanced stages (Laganà et al., 2017). It has 
been reported that red and clear lesions are the most painful, although they are typically 
identified in adolescent patients with lower stages of endometriosis (Marc R. Laufer et 
al., 2003). This finding substantiates the claim that staging has little relationship with 
symptom burden.  
Pain associated with endometriosis can be categorized as dysmenorrhea or CPP. 
The distinction between the two categories is based on painful days per month, with 
dysmenorrhea pain lasting 5-13 days monthly, and CPP pain occurring at least 14 days 
every month (As-Sanie et al., 2013).  Approximately 20-25% of the endometriosis 
population is clinically asymptomatic, experiencing no pain as a result of the disease 
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(Bulletti et al., 2010). This “pain-free” group of endometriosis patients may still 
experience symptoms aside from pain, including infertility and abnormal menstruation. 
Endometriosis commonly affects reproductive capability in women. 
Approximately 30-50% of women diagnosed with endometriosis are infertile (Bulletti et 
al., 2010). Of the infertile women of reproductive age, 50% are also diagnosed with 
endometriosis (Laganà et al., 2017). Although the underlying mechanism responsible for 
the significant correlation between an endometriosis diagnosis and infertility is unknown, 
abnormal pelvic anatomy is a likely cause (Bulletti et al., 2010). Endometrial lesions lead 
to fibrosis and adhesions that distort the tissue, causing inefficient ovum release 
(Mounsey, Wilgus, & Slawson, 2006). IVF can be considered an appropriate method of 
assisted reproduction on a case-dependent basis. 
An endometriosis diagnosis introduces various psychological stressors on the 
patient. Surgical intervention, hospitalizations, medication regimens and delayed 
diagnoses lead to increased costs. As a result, many patients are left with the financial 
burden of their disease. On average, it takes 8-11 years of persistent symptomology 
before an endometriosis diagnosis is made (Riazi et al., 2015).  This delay induces both 
emotional and psychological stress, in addition to financial hardship. Recent literature has 
reported depression and anxiety as the most common disorders comorbidly diagnosed 







Chronic Pelvic Pain Background:  
 
Endometriosis can be differentiated from Chronic Pelvic Pain (CPP), which is 
defined as persistent, noncyclic pain perceived to be in pelvic structures, with a pain 
duration of at least six months (Speer, Mushkbar, & Erbele, 2016). Although CPP affects 
one in seven women, the underlying pathophysiology is generally unknown. The pain 
cannot be directly attributed to a sole identifiable cause, such as menstruation, 
gastrointestinal discomfort, or sexual activity. Endometriosis is often primary to CPP, 
although many cases of consistent pelvic pain are reported without evidence of 
endometrial lesions. Of the population of women with CPP, only 25-38% are diagnosed 
with endometriosis (Kontoravdis et al., 1999). In addition to endometriosis, pelvic pain 
can be secondary fibroids, irritable bowel syndrome, interstitial cystitis, and various other 
disease states affecting the gastrointestinal and genitourinary systems.  
CPP affects 15% of women, and is often accompanied by various comorbidities, 
including irritable bowel syndrome, abdominal wall pain, and endometriosis (Allaire et 
al., 2017). Although the etiology of the disease is unknown, sensitization of the central 
nervous system (CNS) may be the underlying mechanism responsible for the chronicity 
of the pain. CPP has the potential to cause pain in the gastrointestinal, urologic, 
gynecologic, and musculoskeletal systems. As a result of the multifactorial nature of the 
disease, it can be suggested that CNS pain processing, as well as psychologic factors, are 
to blame.  Prior studies have provided evidence of the presence of central sensitization in 
patients with CPP, but it is currently unknown if this centralized pain amplification is the 
cause or effect of chronic pelvic pain (Kaya, Hermans, Willems, Roussel, & Meeus, 
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2013). The literature on pelvic pain has indicated a fundamental role of the CNS in the 
pathogenesis of CPP. It is unknown if central sensitization is secondary to CPP, or if it is 
the cause of the chronic pain. Brain morphology abnormalities, overactive nociceptors, 
and autonomic dysregulation have been reported in studies investigating central 
sensitization and CPP (Kaya et al., 2013). 
Similar to women diagnosed with endometriosis, CPP patients report high levels 
of anxiety and depression. A study by Lagana et al. determined that depression was 
present in 86% of CPP patients, but only 38% of women with pain-free endometriosis. 
Comorbid mood and anxiety disorders further amplify the experience of pelvic pain for 
endometriosis and PP patients (Laganà et al., 2017). Further studies focused on the effect 
of psychological factors on the development of CPP could provide greater insight into 
those at-risk for developing persistent pelvic pain. Women with CPP have a poorer 
quality of life than pain-free women, but the addition of endometriosis does not affect 
psychological well-being (Souza et al., 2011).  
 
Diagnosis and Treatment:  
 
Endometriosis Diagnosis:  
 
Misdiagnosis is a common occurrence, due to the nonspecific symptoms of the 
illness. Shared symptomology with other genitourinary and gastrointestinal illnesses 
provide various differential diagnoses. A British study by Zondervan et al. reported that 
the majority of participants with endometriosis were primarily diagnosed with irritable 
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bowel syndrome (IBS). A third of these women had symptoms of pain for over two years 
prior to an accurate diagnosis (Zondervan et al., 1999).  
 
Table 1: Differential Diagnoses of Endometriosis  
Symptom Differential Diagnosis 
Dysmenorrhea ⋅ Primary 
⋅ Secondary (e.g. myomas, infection, 
adenomyosis, cervical stenosis) 
Dyspareunia  ⋅ Diminished lubrication or vaginal 
expansion due to insufficient arousal  
⋅ Gastrointestinal abnormalities (e.g. 
constipation, IBS) 
⋅ Infection  
⋅ Musculoskeletal abnormalities (e.g. 
pelvic relaxation, levator spasm)  
⋅ Pelvic Vascular Congestion  
⋅ Urinary abnormalities (e.g. urethral 
syndrome, interstitial cystitis) 
Generalized Pelvic Pain  ⋅ Endometritis  
⋅ Neoplasms, benign or malignant  
⋅ Nongynecologic causes  
⋅ Ovarian torsion  
⋅ Pelvic adhesions  
⋅ Pelvic inflammatory disease  
⋅ Sexual or physical abuse  
Infertility  
 
⋅ Anovulation  
⋅ Cervical Factors  
⋅ Luteal phase deficiency  
⋅ Male factor infertility  
⋅ Tubal disease or infection  
Adapted from:  Mounsey, A., Wilgus, A., & Slawson, D. C. (2006). Diagnosis and 
Management of Endometriosis. American Family Physician, 74(4), 594–600.  
 
 
The diagnosis of endometriosis is an imperfect process. Ultrasound, MRI, clinical 
evaluation, and medical history are utilized throughout the diagnostic process. Although 
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laparoscopy is the golden standard of disease state confirmation, less invasive methods 
should be utilized prior to surgery. MRI and ultrasound imaging techniques can help rule 
out other causes of pelvic pain, and assist in the diagnosis (Dessole et al., 2012). Biopsy 
of endometrial tissue has also been introduced as a potentially less-invasive method of 
diagnosis. Pelvic biopsy has a predictive value between 91% (positive predictive value) 
and 96% (negative predictive value). Endometrial density has also been found to be 
fourteen times denser in women with endometriosis . The diagnostic process is the same 
in both adolescents and adult women with suspected endometriosis.  
To date, laparoscopic procedures are performed to visually assess these lesions in 
an effort to both diagnose and stage endometriosis. Due to comorbid pain syndromes, 
laparoscopic exploration is often the only method that can reliably eliminate other 
potential chronic pain illnesses. Staging is based on size, depth, and range of endometrial 
foci, via direct visualization upon laparoscopy. Histological examination of biopsied 
lesions is necessary to confirm an endometriosis diagnosis (Laganà et al., 2017).  
Prior to laparoscopy, medical history and physical examinations are conducted on 
patients with persistent pelvic pain. Clinical signs of the disease include musculoskeletal 
symptoms, fatigue, and menstrual cycle irregularities, including pain. In addition, 
phenotypic physical exam findings such as masses, decreased uterine mobility, adnexal 
tenderness, and nodularity can indicate increased risk of endometriosis (Riazi et al., 
2015). Typically, the report of pelvic pain and dysmenorrhea leads to the suspicion of 
endometriosis, requiring further investigation. Patients suffering from dysmenorrhea are 
2.5 times more likely to have endometriosis than patients without pelvic pain (Treloar et 
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al., 2010). Clinical diagnosis of endometriosis, prior to operative confirmation, is more 
likely with advanced stages of the disease (Riazi et al., 2015). Currently, there is no 
standardized, fully-validated questionnaire that allows the screening of reproductive-aged 
women for endometriosis. Clinicians heavily rely on the gathered medical history to rule 
out low-risk patients, and to refer high-risk endometriosis patients for laparoscopy.  
A genetic biomarker of endometriosis has yet to be discovered. As a result, the 
diagnosis and staging the disease relies on radiology, as well as minimally invasive 
laparoscopic procedures (Galazis & Miskry, 2018). Currently, researchers are 
investigating the diagnostic potential of above-average circulating endometrial cells 
(CECs) quantities in patients with surgically confirmed endometriosis. Unlike 
chemokines CXCL8, CCL5, and CCL2, which have been analyzed as potential 
biomarkers for the diagnosis of endometriosis, CEC levels are unaffected by hormonal 
changes during the menstrual cycle (Chen et al., 2017). This potential biomarker could 





Current treatment is aimed at alleviating the symptoms, specifically pain, 
associated with endometriosis. Endometriosis is an estrogen-dependent disorder, and 
evidence has shown some resistance to progesterone (Johnson et al., 2013). The role of 
estrogen in endometriosis is further highlighted by the cessation of symptoms in post-
menopausal women, with the exception of those who utilize hormone therapy (Stratton & 
Berkley, 2011). The treatment agents include oral contraceptives, androgens, aromatase 
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inhibitors, selective progesterone receptor modulators, and levonorgestrel-releasing 
intrauterine system. Some conventional treatments also decrease the disease state itself, 
although they are not considered curative methods. These treatments include GnRH 
agonists and antagonists, as well as progesterone antagonists (Bulletti et al., 2010).  
When pharmacological methods are ineffective, endometriosis can be treated 
surgically. The effectiveness of surgery at minimizing pain is unrelated to disease stage at 
the time of treatment (Abbott et al., 2004). Ablation of lesions can improve fertility in 
cases of minimal or mild endometriosis (Bulletti et al., 2010). Although surgery does 
alleviate symptoms for a majority of women, approximately 20% of patients experience 
no post-operative pain relief (Abbott et al., 2004).  
 The primary treatment plan for adolescents with endometriosis is targeted at pain 
management. These methods include analgesics such as NSAIDs and hormonal 
management, including OCPs, but are often ineffective. GnRH analogue treatments are 
not indicated for patients under 18 years of age (Dessole et al., 2012). Although previous 
studies have reported that the use of GnRH analogues in adolescent patients can 
negatively impact bone mass, more recent research has determined the potential for 
combined therapy. Divasta et al. discovered GnRH analogues, used in conjunction with 
norethindrone acetate, negate issues regarding bone mass (Divasta, Laufer, & Gordon, 
2007).  
 A successful treatment plan for the population of adolescents resistant to 
treatment by OCPs and NSAIDs includes ablation of endometrial tissue via laparoscopy. 
It is important to note that adolescent endometrial lesions can phenotypically vary from 
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lesions in adult women with endometriosis. It has been reported that red lesions are 
predominantly found in teenagers, while blue or brown lesions are found in older patients 
(Roman, 2010). After laparoscopic ablation is conducted in adolescents, pharmacological 
treatment should be continued in order to target any microscopic remnants of the disease 
(Dessole et al., 2012) . Younger patients are more likely to have post-operative lesion 
recurrence, specifically when conservative surgical methods are used, further validating 
the need for continued medication adherence (Fedele, Bianchi, Zanconato, Bettoni, & 
Gotsch, 2004).   
 
Chronic Pelvic Pain Diagnosis and Treatment:   
 
The diagnosis of CPP is also based on both the physical exam and the patient’s 
medical history. Oftentimes, patients undergo laparoscopy, only to rule out an 
endometriosis diagnosis. CPP can persist, despite targeted gynecologic treatments of 
endometriosis. Oftentimes, the patients with continued discomfort also suffer from 
various comorbid pain syndromes, including central sensitization (Allaire et al., 2017). 
Due to the various comorbidities associated with CPP, treatment plans are often targeted 
at specific symptoms. Curative treatments of CPP are currently unknown, and the disease 
is often refractory to current methods. By identifying specific underlying causes, 
physicians can potentially ameliorate symptomology.  
A study by Laufer et al. on 32 adolescents below the age of 22 years investigated 
the etiology of persistent pelvic pain in those resistant to conventional treatments (M. R. 
Laufer et al., 1997). Only 69.6% of these patients were found to have endometriosis, 
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indicating that one third had no known cause of their pain. Considering the side effects of 
invasive surgery, advances in the clinical diagnosis of CPP are needed to avoid 
unnecessary operations.  
The current use of laparoscopy to both diagnose endometriosis and rule out 
endometriosis in CPP patients, comes with various well-known side effects. Surgery 
should be avoided when possible, but other diagnostic measures of endometriosis are 
limited. Non-operative methods, that can be used clinically, are vital to improving the 
standard of care of pelvic pain patients. Standardized clinical methods could both 
expedite diagnosis time and ameliorate the diagnostic process overall. There is no self-
reported questionnaire that exists to allow for the symptom-based screening of 
endometriosis. A validated questionnaire, in addition to a physical pelvic examination, 
would provide a non-invasive, reliable method of diagnosis. Those patients most at risk 
based on this assessment could then undergo laparoscopy for staging and confirmation of 
the disease state. This method would eliminate the need for surgery of those suffering 
from chronic pelvic pain, who are unlikely to have endometriosis.  
 
 
Central Sensitization  
 
 Central Sensitization (CS) is the hyperactivity of the central nervous system in 
response to stimuli (Kaya et al., 2013). As defined by Fleming et al., the enhanced 
sensitivity is secondary to neuronal plasticity that increases sensitivity to future stimuli 
(Fleming & Volcheck, 2015). The two components of central sensitization are allodynia, 
when innocuous stimuli cause pain, and hyperalgesia, when mildly painful stimuli cause 
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heightened pain levels. Allodynia, a painful sensation caused by light touch, has been 
indicated in patients with advanced stages of endometriosis. The mechanism behind 
allodynia is poorly understood, although research has implicated both nervous system 
mechanisms, including phenotypic changes in peripheral and central neurons, as well as 
immune mechanisms (Lolignier, Eijkelkamp, & Wood, 2015).  Evidence has shown that 
the hypersensitivity is amplified by the spinal dorsal horn, limbic system, and cortical 
structures (Simis et al., 2015). 
There is significant comorbidity between chronic pain conditions, including 
fibromyalgia and CPP. Overlap not only exists in the diagnosis of these diseases, but also 
in their symptomology, including abdominal bloating, chronic pelvic pain and anxiety 
(Fleming & Volcheck, 2015). The commonalities between these chronic pain conditions 
suggest a shared underlying mechanism, such as CS. Several studies have reported a 
decreased dermal and muscular pain threshold to various stimuli in CPP patients 
(Giamberardino, Tana, & Costantini, 2014). Using fMRI, brain activity changes resulting 
from CS can be visualized, and therefore targeted. Proposed treatments of central 
sensitization include non-invasive brain stimulation and techniques aimed towards the 
CNS.  
 
Quantitative Sensory Testing 
Quantitative Sensory Testing (QST) allows the delineation of somatosensory 
functioning, including peripheral nerve fibers and CNS mechanisms (Blankenburg et al., 
2010). QST methods utilize the use of thermal, mechanical, electrical and chemical 
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stimuli to assess detection and pain thresholds. Detection thresholds require the 
participant to report the first recognition of the applied stimuli. This could include the 
detection of a von Frey hair (a series of increasingly thick nylon filament), or the 
detection of a temperature change on thermal testing. Pain thresholds ask the participant 
to report the maximum application of stimuli that they are able to sustain on their skin. 
Typical pain thresholds include thermal application, both hot and cold, or pressure using 
a pressure algometer or a pressure cuff. QST is a validated measure of somatosensory 
testing in both children (Blankenburg et al., 2010) and adults (Moloney, Hall, & Doody, 
2012) 
QST has been implicated as a necessary medium when assessing the prevalence 
of central sensitization in patients with CPP (Giamberardino et al., 2014). A recent study 
by Antolak & Antolak (2018) utilized QST protocols in men diagnosed with CPP. 
Abnormal pain thresholds were discovered in the majority of participants, using warm 
detection thresholds (88%) and pinprick sensation detection (92%) (Antolak & Antolak, 
2018). Abdominal pain and detection QST protocols have been utilized in women, 
without significant findings (Whitaker et al., 2016). To date, there is a substantial gap in 
the literature regarding the relationship between central sensitization, as measured by 









Specific Aims and Objectives 
 
 This study aims to explore the relationship between central pain amplification and 
persistent pelvic pain. No previous studies have utilized bimanual examination findings, 
in addition to pressure-pain analysis, in an effort to investigate central sensitization. 
Evidence has shown a positive relationship between chronic pain syndromes and 
centralized pain. The following hypotheses are suggested based on the categorization of 
CPP as a chronic pain syndrome: 
 
Aim I:  
 To determine which participant groups (Endo Ø Pain, Endo + Pain, CPP Ø Endo, 
and Healthy Controls) have the lowest pressure-pain thresholds, as measured by QST 
testing on the non-dominant thumbnail.  
Hypothesis I:  
 Patients with CPP Ø Endo will therefore report the lowest pressure pain threshold 
on QST testing. Endometriosis patients with pain will report the next lowest pressure pain 
threshold. Significant differences between the healthy controls and the Endo Ø Pain 
groups are not anticipated. 
 
Aim II:  
 To determine which groups report the highest levels of tenderness during the 
pelvic bimanual examination.  
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Hypothesis II:  
 Patients in the CPP Ø group, as well as the Endo + Pain group, will report the 
highest number of pelvic exam tenderpoints. Patients in the Endo Ø Pain group will not 
significantly differ from Healthy Controls on tenderness during the bimanual pelvic 
exam.  
 
Aim III:  
 To determine the relationship between pain reported during the pelvic 
examination and thumbnail pressure pain.  
Hypothesis III:  
 Pressure-pain thresholds will negatively correlate with pain levels reported during 
the pelvic examination. Patients experiencing high levels of tenderness during the pelvic 
exam will also report greater sensitivity during the thumbnail pressure assessment.  
 
Aim IV:  
 To determine the relationship between reported pelvic tenderness, pressure-pain 
thresholds, and the number of comorbid chronic pain syndromes.  
Hypothesis IV:  
 Patients with a greater number of comorbid chronic pain syndromes will report 







 This study was completed as a collaborative project between the 
Biobehavioral Pain Laboratory in the Department of Psychiatry and Anesthesia at Boston 
Children’s Hospital (BCH) and the Michigan Medicine Von Voigtlander Women’s Clinic 
at Von Voigtlander Women’s Hospital. The Institutional Review Board at the University 
of Michigan approved this study as a means of collecting data from human participants in 
an effort to study endometriosis. Potentially eligible participants were approached during 
their clinical visits at Michigan Medicine. This study utilized obtained surgical notes and 
imaging, self-reported pain questionnaires, quantitative sensory testing, and a bimanual 
pelvic examination. All participants provided informed consent prior to the onset of their 





Women with CPP and/or endometriosis, aged 18-50 years were recruited from 
local advertisements and a pelvic pain referral center. Age-matched healthy controls were 
recruited from local advertisements. All study participants received $40 compensation.  
Phone interviews were conducted to screen potential participants. Requirements 
for the pain subgroups included a surgically confirmed history of endometriosis or 
chronic pelvic pain, as well as a performed pelvic surgery within the past five years. 
Pain-free women with no history of pelvic pain, endometriosis, or chronic pain syndrome 
were recruited as healthy controls. Potential participants were screened with the M.I.N.I. 
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International Neuropsychiatric Interview, a diagnostic interview used to assess 
psychiatric illness (Sheehan et al., 1998). Potential healthy controls with psychotic, 
mood, or anxiety disorders were excluded. Studies have shown that up to 70% of patients 
diagnosed with a chronic pain syndrome also suffer from comorbid depression and 
anxiety (de Heer et al., 2014). As a result, endometriosis and chronic pelvic pain 
participants with comorbid mood or anxiety disorder were included in this study, but 
those meeting criteria for psychotic illness were excluded. A history of suicide attempt or 
substance abuse within two years of the study were additional exclusionary criteria for 
this study. Participants with severe physical impairment were also excluded.  
Various measures were taken to minimize the influence of hormonal variability in 
all participants. Included participants had no history of prior hysterectomy or 
oophorectomy. Pregnant, lactating, or menopausal women were also excluded from 
participation. For this study’s purposes, menopause was defined cessation of menses for 
12 consecutive menses, unrelated to exogenous hormonal influences. Additionally, all 
QST was performed on participants between days 2 and 10 of the menstrual cycle, in an 
effort to decrease the effects of hormone fluctuation. Participants taking hormonal 
contraceptives were able to complete study visits at any point in their menstrual cycle. 
Participants were asked to abstain from opioid analgesic use within 48 hours of the study 
visit. 
 Participants were categorized into groups based on self-reported questionnaires, 
medical history, and diagnosis at surgery. Classifications included endometriosis with 
pain (Endo + Pain), pain-free endometriosis (Endo Ø Pain), and chronic pelvic pain 
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without endometriosis (CPP Ø Endo). Endometriosis patients suffering from both 
dysmenorrhea and CPP were grouped into the Endo + Pain group. Although prior studies 
have further separated these endometriosis patients into two pain subgroups 
(endometriosis with CPP and endometriosis with dysmenorrhea), no significant 
differences were found between the groups (As-Sanie et al., 2013). As previously defined 
by this group, CPP is defined as moderate to severe pelvic pain that is ≥ 4 (on a 0-10 
pain rating scale where 10 is the most painful), lasting at least 6 months, and occurring at 
least 14 days monthly. Dysmenorrhea is defined as moderate to severe pelvic pain that is 
≥ 4 (on a 0-10 pain rating score), lasting at least 6 months, but only occurring 5-13 days 
each month. Dysmenorrhea pain typically occurred around the time of menstrual 
bleeding, whereas CPP is typically unrelated to menses. Participants categorized in the 
Endo Ø Pain group reported fewer than 4 days of moderate or severe pelvic pain per 
month.  
The majority of patients were previously diagnosed, prior to the study, at a 
different medical institution. When available, surgical biopsy and pathology 
documentation was utilized to corroborate diagnoses. Operative case reports were 
completed, depicting the physical characteristics of the endometriosis, including location, 
severity and pelvic adhesive disease. Surgical biopsy and pathology were not required, 
but were utilized when available. Any presence of endometriosis was staged in 
accordance with the revised American Fertility Society endometriosis scoring system 
(“Revised American Society for Reproductive Medicine classification of endometriosis,” 
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1997) For the purposes of this study, operative reports were reviewed by an 
endometriosis expert, blind to study results.  
All participants completed both demographic and medical history questionnaires. 
Medical questionnaires assessed surgical history, medication use, and menstrual pattern. 
The Complex Medical Symptom Inventory (CMSI) was administered to evaluate 
participants for the existence of chronic cormorbid pain syndromes (CPS), including 
fibromyalgia, chronic fatigue syndrome, interstitial cystitis, irritable bowel syndrome, 
chronic lower back pain, chronic migraine headache, temporomandibular disorder, and 
vulvodynia (Williams & Schilling, 2009). Evidence has shown that the above listed 
chronic pain syndromes are associated with CNS pain amplification (Phillips & Clauw, 
2011). As a result, many chronic pain syndromes have a shared underlying mechanism. 
Participants diagnosed with endometriosis and/or CPP, as well as a CPS, were included 
in this study, due to the high prevalence of comorbid chronic pain syndromes. Potential 
healthy controls were excluded if they met the criteria for any pain syndrome, as assessed 
by the CMSI.  
Participants in the three pelvic pain groups were asked to complete additional 
questionnaires aimed at assessing their history of pelvic pain, including severity, pattern, 
symptom characteristics and prior treatment plans. Participants numerically rated the 
severity of their pelvic pain and physical discomfort on a scale of 0-10 (0 as no pain, 10 
as the worst pain). They also reported the average number of days per month in which 
they suffered from moderate to severe pelvic pain. Pain patients provided written consent 
allowing the release of their most recent operative reports, which were then reviewed. 
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The reviewer of the operative reports was blinded to all other study data, and had a 
significant expertise in surgical evaluation of gynecological disorders, including 
endometriosis.  
 
Quantitative Sensory Testing:  
In order to determine individual sensory and pain thresholds, Quantitative 
Sensory Testing (QST) was performed on all participants. As defined by Cruz-Almeida 
and Fillingim (2018), “QST refers to a group of procedures that assess perceptual 
responses to systematically applied and quantifiable sensory stimuli for the purpose of 
characterizing somatosensory function or dysfunction.” For the purposes of this study, a 
research coordinator administering the QST testing was blinded to all other study data. 
Prior research provided a specific QST staircase method that allowed the 
assessment of pressure-pain in fibromyalgia patients (Harris et al., 2006). Previously 
published studies described the adaptation of this QST staircase method for chronic 
pelvic pain patients (As-Sanie et al., 2013).  The QST was conducted by administering 
ascending pressure stimuli to the non-dominant thumbnail of all participants in an effort 
to assess centralized pain amplification. The application of pressure allowed the 
quantification of self-reported pressure-pain sensitivity, using the Gracely Box Scale 
(GBS), a 0-20 numerical descriptor scale (Gracely, Petzke, Wolf, & Clauw, 2002). The 
pressure apparatus uses calibrated weights, applied to a hydraulic piston that produces 
controlled pressure using water-filled tubing to a second piston with a 1 cm2 rubber 
probe. As an ascending staircase, the applied pressure was applied in an increasing 
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manner, from 0.25 kg/cm2 up to a maximum pain tolerance, or to 10 kg/cm2. Ascending 
pressure was applied in increments of 0.25-0.5 kg/cm2. The GBS was used to record 
perceived pain intensity at each pressure along the ascending pressure series. These 
results were used to determine the starting point for the individualized staircase pressure 
administration.  
 The response-dependent multiple random staircase pressure application was then 
applied to the non-dominant thumbnail. The 36 stimuli delivered were applied at 20 
second intervals to the thumb. Based on the participant’s self-reported pain rating, the 
intensity (kg/cm2) needed to elicit a specific response was determined. A computer 
program utilized these pain ratings to adjust the stimulus intensity, randomly applying the 
pressure needed to elicit “faint”, “mild”, and “slightly intense” pain. According to the 
GBS, faint pain measures as a 0.5, mild pain as a 7.5, and slightly intense pain as a 13.5 
on the 0-20 descriptor scale. Currently, no standardized norms for pressure-pain analysis 
in endometriosis and chronic pelvic pain patients exist. A prior fibromyalgia study 
utilizing QST provided evidence that a 1.5 kg/m2 difference in pressure (SD= 2.0) will 
induce pain in chronic pain patients, as compared to healthy controls (Giesecke et al., 
2003). Accordingly, this study utilized this value when determining the pressure 
increments (kg) for the ascending staircase.  
 
 
Physical Exam:  
 
In order to guarantee consistency throughout the study, every physical exam was 
performed by Sawsan As-Sanie, MD, a board-certified obstetrician-gynecologist. A 
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standardized case report used to assess location and summary of internal and external 
tenderness was completed throughout the physical examination. Prior to the exam, 
participants were given a figure of an anatomical figure (shown below), and asked to 























Figure 2: Abdominal Quadrants  
 
External systemic tenderpoints were assessed by the standardized criteria for 
fibromyalgia diagnoses, in an effort to assess centralized pain.  Due to a lack of imaging 
or lab test for the diagnosis of fibromyalgia, a physical exam consisting of 18 potential 
tenderpoints is widely used. For the purposes of this study, the fibromyalgia tenderness 
exam was used to evaluate centralized pain mechanisms in the patient population, as 
	
25 
compared to healthy controls. These sum of the individual’s tenderpoints were then 



























Figure 3: Fibromyalgia Tenderpoints 






External Tenderness:  
 
An external physical exam was performed on the gynecological 
participant sample to determine areas of tenderness and discomfort. This 
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participant sample included those diagnosed with chronic pelvic pain and/or 
endometriosis, but did not include healthy controls. To assess abdominal 
tenderness, the four quadrants of the abdomen were palpated manually as the 
patient was asked to report any tenderness experienced. Using a standardized 
physical examination protocol, areas of potentially reported abdominal tenderness 
included right upper quadrant (RUQ), left upper quadrant (LUG), right lower 
quadrant (RLQ), left lower quadrant (LLQ), suprapubic, and periumbilical 
regions.  
During the study visit, allodynia was defined as painful sensation 
experienced during the light touch across the abdominal wall. The pattern of 
abdominal tenderness was also assessed upon external exam, and was categorized 
as diffuse, focal, not localized, or no-pain. “Diffuse” tenderness was defined as 
crossing into more than one quadrant. “Focal” tenderness was defined as being 
reproducible in only one small area (<1 inch in diameter). “Not localized” 
tenderness was defined as non-reproducible pain on abdominal exam. The number 
of trigger points was also determined during external physical exam. The focal 
point of tenderness was assessed, as well as reproduction of 50% of the chief 
complaint. It was also determined if these trigger points worsened with abdominal 








Internal Tenderness:  
 
Participants in the gynecological sample (CPP Ø Endo, Endo + Pain, Endo 
Ø Pain) underwent a single digit pelvic examination, as well as a bimanual exam. 
The single digit exam was used to identify vulvar or vestibular tenderness, pain 
near the ischial spine, bladder/urethral tenderness, as well as pelvic floor 
tenderness. Using a pressure algometer, pelvic floor sensitivity was assessed, 
targeting the levator ani, obturator internus, and piriformis muscles. 
Approximately 2kg of pressure was applied to specific internal regions, and 
participants were asked to give a score from 0-10, where 0 indicated no pain 
whatsoever, and 10 indicated the worst imaginable pain. Currently, there is no 
standardized protocol that can be utilized to examine these values.  
The standard bimanual exam was also performed in order to identify any 
potential abnormal findings. Central uterine tenderness was defined as pain with 
moving of the cervix, uterosacral ligament, and/or the uterus. Uterine size (normal 
versus enlarged) and mobility (freely limited versus limited mobility) were 
assessed. Uterosacral nodularity, adnexal mass and tenderness, and rectovaginal 
masses were also investigated via internal palpation. The pattern of identified 
pelvic tenderness was categorized as “diffuse”, “focal”, “not localized”, or “no 
pain” on the standardized exam report. Location of the ‘worst’ pain was 
determined as well as a brief summary of the discomfort experienced by the 
patient in that region. “Worst” pain locations included abdominal wall, pelvic 
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floor, vagina, vulva, uterus/cervix, suprapubic, and adnexa. These six regions 


























Statistical Analyses:  
 
All analyses were performed using SPSS, version 23 (IBM Corp., Armonk, NY). 
ANOVA and Chi-square analysis was performed to see how participant subgroups varied 
for both demographics and specific medical variables. Continuous variables between 
groups were analyzed using one-way ANOVA tests. Categorical data, such as race, 





 Two correlational analyses were conducted in order to explore significant 
differences between participant subgroups, when looking at the association between the 
pressure staircase and reported tenderpoints (internal and external). A primary score for 
pelvic exam tenderpoints was calculated as the sum of the number of areas identified as 
tender during the pelvic exam. Correlations were run between the total external 
tenderpoints and all (low, medium, and high) pressure-pain QST. Correlations were also 
run between the pressure pain staircases and total internal tenderpoints, as measured upon 
physical exam.  
   
 
Generalized Linear Models  
 
 Generalized Linear Models (GLM) were used to further explore the physical 
exam findings on low and high pressure-pain thresholds. Two separate generalized linear 
models were performed, one using the individualized lowest staircase QST pressure (used 
to indicate faint discomfort), and another using the individualized highest pressure 
(indicating “slightly intense” pain). Both pressure pain variables were natural-log 
transformed to create two versions of the pain rating score. Both age and number of 
comorbid chronic pain syndromes were controlled throughout all GLM analyses. A GLM 
was also conducted to examine variation across the gynecological groups (CPP Ø Endo, 
Endo Ø Pain, Endo + Pain) on pelvic exam tenderpoints. The total pelvic tenderpoints 
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score was natural log transformed prior to GLM analysis. The healthy controls did not 
undergo a pelvic exam, and were therefore excluded from this GLM.  
Analyses were conducted using Version 23 of SPSS for Windows. All p-values were 2-








Participant Sample:  
	
A total of 144 pre-menopausal women participated in this study. The participants 
included 30 healthy controls, and 122 women diagnosed with CPP or endometriosis. Due 
to missing data, 8 women in the gynecological sample were excluded from data analysis, 
leaving 30 healthy controls and 114 patient participants. Based on clinical diagnoses, 
relevant surgical evidence, and medical history, participants were categorized into 3 
subgroups. Of the gynecological sample, 35 women were categorized in the 
endometriosis without pelvic pain group (Endo Ø Pain), 57 women were categorized as 
endometriosis with pelvic pain, including dysmenorrhea and CPP (Endo + Pain), and 22 
were categorized as Chronic Pelvic Pain without endometriosis (CPP Ø Endo). 
The sample was predominantly caucasian (83.8%). The women in this sample 
were aged 18-50 years (mean= 31 years, SD= 7.99). One-way ANOVAs looking at 
groups differences in age were conducted; F(3, 140) = 5.53, p = 0.001). Post-Hoc Scheffe 
tests were conducted, showing significant mean age differences. A significant age 
difference was found between Endo Ø Pain (n=35, mean= 35.45 years) and Endo + Pain 
(n=57, mean = 28.75 years) subgroups, where patients without pain were significantly 
older (difference=6.79, p <0.05). No other between-group age comparisons were found to 
be statistically significant.  
When comparing patient subgroups, there were no significant differences in 
number of prior pregnancies, abdominal surgeries, or pelvic pain treatment surgeries. No 
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differences between groups were found regarding the current use of hormonal 
contraception, and of these women, all were taking either estrogen-progestin or 
progestin-only contraceptives (As-Sanie et al., 2013). There were no significant 
differences in body mass mass index (BMI) between participant subgroups (n= 149, 
mean = 26.2, range= 18.61- 42.92). Chi-square analysis were used to assess categorical 
variables. No significant differences were found in occupation, education, or race 











































Medical Variables:   
 
A One-way ANOVA analysis was conducted to examine years since last surgery 
between Endo Ø Pain, Endo + Pain, and CPP Ø Endo subgroups; (F(2, 108)= 3.691, p= 
0.028). Post-Hoc Scheffe tests determined that Endo + Pain (n=54, mean= 1.80) had 
significantly more time (years) since last surgery than the CPP Ø Endo (n=22, mean= 
0.74) subgroup (difference = 1.06, p < 0.05). CPP Ø Endo subgroup had surgical 
intervention more recently than the Endo + Pain subgroup. No other significant 
differences were found between subgroups when considering years since surgical 
intervention. Healthy controls were not included in this analysis. 
No significant differences in pain duration (years) were found between groups. 
Post-Hoc Scheffe tests were conducted to compare endometriosis stage between the two 
endometriosis patient subgroups. It was discovered that the Endo Ø Pain group (n= 35, 
mean= 2.74) had a significantly higher stage of endometriosis than the Endo + Pain (n= 
55, mean= 2.09) group at the time of the initial study visit (difference= 0.652, p <0.05).  
 Using the fibromyalgia criteria, external systemic tenderpoints (range= 0-18) were 
tested throughout the body. One-way ANOVA was conducted to determine differences 
between participant subgroups (F(3,104)=10.786, p = 0.000). Healthy controls had 
significantly less tenderpoints (n= 30, mean= 1.47) than all patient subgroups, including 
Endo Ø Pain (n= 29, mean= 4.83), Endo + Pain (n= 42, mean= 6.93), and CPP Ø Endo 
(n= 7, mean= 9.00).  Healthy controls had significantly less tenderpoints than Endo Ø 
Pain (difference= -3.361, p <0.05), Endo + Pain (difference = -5.462, p < 0.01), and CPP 
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Ø Endo (difference = -7.533, p < 0.05). No significant differences were found between 
the patient subgroups.  
 Chronic comorbid pain syndromes (CPS) were also analyzed using one-way 
ANOVA analyses. Significant differences between healthy controls (mean= 0.07) and 
Endo + Pain (mean= 1.73) were found. Participants with CPP Ø Endo (mean= 2.29) also 
had significantly more CPS than healthy controls. No significant differences were found 
between controls and the Endo Ø Pain (mean= 0.63) groups. Significant differences were 
found between the Endo Ø Pain and Endo + Pain subgroups, as well as the Endo Ø pain 
and CPP Ø Endo subgroups. Participants with CPP were found to have greater comorbid 
chronic pain syndromes than both healthy controls and participants with endometriosis, 
but no pain. During the physical exam, the periumbilical and suprapubic regions were 
also assessed, although no participants, in any subgroup, reported tenderness in these 
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Pearson correlations were conducted in order to analyze the correlational 
relationship between total pelvic exam tenderpoints, systemic external tenderpoints, and 
pressure- pain staircases (low and high; kg). Significant correlations were found between 
various continuous variables.  
Pelvic exam tenderpoints were negatively correlated with low pressure-pain 
threshold (r= -0.31, p < 0.01). Systemic external tenderpoints were also negatively 
correlated with low pressure pain threshold (r = -0.35, p <0.01). These negative 
correlations signify that the lower the threshold for low pressure-pain upon QST testing 
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moderately correlates with a higher number of both systemic and pelvic tenderpoints. The 
high pressure staircase was found to be negatively correlated with the total systemic 
external tenderpoints (r= -0.41, p < 0.01). For the high pressure staircase, there was no 
significant correlation to pelvic examination tenderpoints. The total number of systemic 
external tenderpoints was positively correlated (r= 0.27, p < 0.05) with pelvic exam 
tenderpoints. The high pressure staircase stimulus was positively correlated with the low 
pressure staircase (0.53, p < 0.01).  
 
 
















Pearson Correlation 1 -.314** -.163 .267* 
N 95 89 89 69 
Low Staircase 
(kg) 
Pearson Correlation -.314** 1 .533** -.354** 
N 89 147 146 110 
 High Staircase 
(kg) 
Pearson Correlation -.163 .533** 1 -.414** 




Pearson Correlation .267* -.354** -.414** 1 
N 
69 110 110 118 
**. Correlation is significant at the 0.01 level (2-tailed). 









Generalized Linear Models  
  
Generalized Linear Models (GLM) were conducted to explore significant 
differences between groups on pressure-pain thresholds (low and high), while controlling 
for age and number of comorbid chronic pain syndromes (CPS). In this model, there are 
factors, which are categorical variables, as well as covariates, which are continuous 
variables. In the current model, covariates included age and CPS. The low pressure-pain 
staircase and high pressure-pain staircase was natural log transformed in order to 
normalize the data set, prior to conducting GLMs with the dependent variables. The 
GLM was conducted three separate times, with the dependent variables including low 




The GLM was conducted to examine low pressure-pain threshold as a dependent 
variable across the four participant groups with age and CPS as covariates. The mean low 
pressure-pain threshold was 1.03 kg, SD= 0.91.  Significant differences emerged between 
the groups on this model, holding age and CPS constant. Bonferroni post-hoc analyses 
revealed the following significant differences in pairwise comparisons: Endo Ø Pain had 
significantly higher low pressure-pain threshold compared to both Endo + Pain 
(difference = 0.57, p < 0.01, CI= 0.12, 1.02) and healthy controls (difference = 0.55, p < 
0.05, CI= 0.08, 1.02). The omnibus test, used to compare the fitted model against the 
intercept-only model, determined that the model is significant (p < 0.01). 
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High-Pressure Threshold:  
 
The GLM was conducted to examine high pressure-pain threshold as a dependent 
variable across the four participant groups with age and CPS as covariates. The mean 
high pressure-pain threshold was 4.10 kg, SD= 1.96.  Significant differences emerged 
between the groups on this model, holding age and CPS constant. Bonferroni post-hoc 
analyses revealed the following significant differences in pairwise comparisons: the CPP 
Ø Endo group had significantly lower high pressure-pain threshold scores compared to 
healthy controls (difference = 0.38, p < 0.05, CI= 0.05, 0.71). The Endo + Pain group 
also had significantly lower high-pain thresholds as compared to healthy controls 
(difference= 0.31, p < 0.05, CI= 0.04, 0.58). The omnibus test determined that the model 
is significant (p < 0.05).  
 
Pelvic Exam Tenderpoints:  
 
A GLM was conducted to explore the differences between the gynecological 
participant groups (CPP Ø Endo (n= 16), Endo Ø Pain (n=28), and Endo + Pain (n=41)) 
on pelvic exam tenderpoints, once again controlling for age and CPS. Bimanual pelvic 
examinations were not performed on healthy controls in this study, therefore healthy 
controls were excluded from this generalized linear model. The mean total pelvic exam 
tenderpoints for the sample was 2.54 (range= 0-9, SD= 2.25). Bonferroni post-hoc 
analyses revealed the following significant differences in pairwise comparisons: the CPP 
Ø Endo group had significantly more pelvic tenderpoints compared to Endo Ø Pain 
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(difference = 2.81, p < 0.001, CI = 1.36, 4.27); Endo + Pain group also had significantly 
more pelvic exam tenderpoints than the Endo Ø Pain (difference= 2.10, p < 0.001, CI = 






The high prevalence of persistent pelvic pain among women of reproductive age 
creates a demand for improved understanding of endometriosis and CPP. In the general 
population, the incidence of endometriosis in women of reproductive age is estimated to 
be 10% (Mounsey et al., 2006).  Studies have shown that CPP in women aged 18-50 
directly accounts for $881.5 million per year in medical costs (Mathias, Kuppermann, 
Liberman, Lipschutz, & Steege, 1996). Between associated pain, delayed diagnosis, and 
treatment aimed at symptoms, clinical advances are needed.  
This study aimed to explore the relationship between centralized pain and pelvic 
pain, in women diagnosed with endometriosis and/or CPP. By using pressure-based 
quantitative sensory testing (QST), pressure-pain thresholds were determined for all 
participants. Physical examinations, both internal and external, allowed tenderness to be 
assessed clinically across the gynecological sample. Similar to endometriosis, the 
pathogenesis of CPP is not fully understood. Research has indicated that central 
sensitization has a role in the underlying mechanism of the disease, specifically in the 
chronic nature of the pain (Kaya et al., 2013). 
The standardized protocol used for the pelvic (single digit and bimanual) exams 
allowed for consistency throughout this study. Additionally, all physical exams were 
conducted by the same physician, further standardizing the process. The researcher that 
administered the QST to the participants was blinded to all other study results, 
eliminating experimenter bias when determining pressure-pain sensitivity. Another 
strength of this study is the accuracy of participant categorization into the three patient 
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groups. The use of medical history, surgical diagnoses, operative case reports, and 
relevant pathology allowed confidence in group classification by limiting the potential for 
misdiagnosis. The QST protocol was performed by a single researcher, blinded to all 
other study results, providing consistency and eliminating bias. Additionally, a single 
physician conducted the bimanual pelvic examinations, adding an additional layer of 
consistency throughout all patient visits.  
Endo Ø Pain patients were found to be significantly older than Endo + Pain 
patients. There are various possible explanations for this finding, including poorly age-
matched participant recruitment, age at diagnosis, and delayed diagnosis. Previous 
studies have found that the probability of diagnosis increases with age, as does the 
severity of symptoms (Bulletti et al., 2010). Future research should continue to look age 
age as a risk factor for pain associated with endometriosis. As reported by The 
Endometriosis Association, two thirds of women with endometriosis, regardless of age at 
diagnosis, report the onset of pelvic pain prior to 20 years of age (Dessole et al., 2012). 
Future research focusing on adolescents most at risk for endometriosis and CPP could 
provide further insight into the disease. 
It was determined that CPP Ø Endo group had surgery more recently than the 
Endo + Pain group. Pain duration (in years) between these groups did not differ, 
indicating that the CPP Ø Endo group had a greater delay in diagnosis than the Endo + 
Pain group. Both patient groups were experiencing pain as a major symptom of their 
illness, but those with endometriosis received an operatively confirmed diagnosis earlier. 
This finding suggests that women with Chronic Pelvic Pain, but without endometriosis 
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lesions, have an even harder time receiving accurate clinical diagnoses.  Prior studies 
have determined that the probability of clinical diagnosis increases with endometriosis 
stage (Riazi et al., 2015), further delaying the diagnostic process for women with CPP 
without secondary endometriosis.   
Pain-free endometriosis participants were found to have a higher stage of the 
disease than the endometriosis group with CPP or dysmenorrhea. Several studies have 
found no relationship between endometriosis stage and symptom burden (Laganà et al., 
2017).  Similarly, a recent study on post-operative pain in spinal patients found that pain 
was unrelated to severity of disease (Sieberg et al., 2013).  
External systemic tenderpoints were assessed on the physical exam, as a method 
of determining centralized pain. As expected, healthy controls had significantly fewer 
external tenderpoints than all patients in the gynecological sample. No differences were 
found between patient groups, suggesting that all diagnoses of pelvic pain shared an 
underlying centralized pain mechanism. Many patient participants also reported comorbid 
chronic pain syndromes (CPS), which could also be related to the development of central 
sensitization. Research has shown a high prevalence of central sensitization in patients 
with CPS, including fibromyalgia (FM), IBS, and interstitial cystitis (Phillips & Clauw, 
2011).  
Analysis of CPS discovered that Endo + Pain and CPP Ø Endo had significantly 
more comorbid illnesses than healthy controls. Participants of these two groups share a 
common symptom of pain, indicating a similar centralized pain amplification process. 
The Endo Ø Pain did not differ significantly from healthy controls, suggesting that the 
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associated pain, not the endometriosis diagnosis, is responsible for the shared underlying 
mechanism of CPS. This finding suggests that the pain, not the endometrial lesions, are 
responsible for the central pain amplification secondary to persistent pelvic pain. Women 
suffering with painful endometriosis, whether experiencing dysmenorrhea or chronic 
pelvic pain, are more likely to have a comorbid secondary CPS than pain-free 
endometriosis patients.  
Pelvic examinations, including abdominal palpation and internal tenderness 
assessment, were performed on patients in the gynecological sample. External 
tenderpoints for the pelvic exam included the right upper quadrant, left upper quadrant, 
right lower quadrant and left lower quadrant abdominal regions. Internal tenderpoints 
were assessed by single-digit and bimanual exams. The sum of pelvic exam tenderpoints 
was significantly correlated with the total number of systemic external tenderpoints, used 
to assess centralized pain. This finding suggests that internal tenderness is another 
identifier of central sensitization. Future studies on patients with chronic pain could 
utilize an internal tenderpoint assessment, via pelvic exam, in conjunction with the 
current external tenderpoint identification protocol. Generalized linear models analyzing 
total pelvic exam tenderpoints between groups found that both the CPP group without 
endometriosis and the painful endometriosis group had more tenderpoints than the pain-
free endometriosis sample. As a result, internal tenderpoints can be a useful measure of 
identifying both chronic pelvic pain and central sensitization.   
 Pain thresholds, as measured by QST pressure-pain testing, were found to be 
significantly correlated with both pelvic exam tenderpoints and external systemic 
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tenderpoints. It was determined that a higher number of tenderpoints, identified both 
externally and internally, correlated with lower the pressure-pain threshold.  This finding 
suggests that patients experiencing clinical tenderness also have lower thresholds for 
pressure in non-painful areas, such as the thumbnail. Similar findings were identified for 
systemic external tenderpoints on the higher pressure-pain thresholds. For the high 
pressure staircase, no relationship was found with pelvic exam tenderpoints.  
 When pressure-pain was further delineated between groups, it was found that 
pain-free endometriosis patients had higher low-pain thresholds than painful 
endometriosis participants. This finding suggests that CPP and dysmenorrhea associated 
with endometriosis could lead to the development of central sensitization, not the 
endometriosis diagnosis itself. When analyzing the high-pressure pain threshold between 
groups, the CPP without endometriosis and the painful endometriosis groups had lower 
pain thresholds than healthy controls. This further confirms that the addition of 
endometriosis does not affect amplified pain measured by QST, but pelvic pain does. 
These differences cannot be attributed to other significant differences between groups, 
including age and CPS.  
 No participants reported pain in the periumbilical or suprapubic regions during 
the physical exam, regardless of their group categorization. This finding may suggest that 
these regions are not affected by centralized pain amplification. Additionally, no 
participants reported skin allodynia during the examination. Previous studies have found 
a positive correlation between reduced pressure-pain threshold and abdominal and 
perineal allodynia in women with CPP (Jarrell, Malekzadeh, Yang, & Arendt-Nielsen, 
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2015). This study did not test for perineal allodynia, therefore it is unknown if the 
participants had hypersensitivity to light touch in this region. Bedside testing of central 
sensitization by assessing allodynia has been validated, and should be continued with 
pelvic pain patients to further understand this symptomology (Jarrell et al., 2015). Prior 
research has discovered that phenotypic changes in both neurons and immune cells are 
implicated in the etiology of allodynia, a discovery that further connects the CNS and 
centralized pain (Lolignier et al., 2015).   
The delay in diagnosis is a source of major frustration for women suffering from 
endometriosis. Early diagnosis will not only lessen the financial burden of unnecessary 
testing, but also years of suffering without adequate treatment. Non-invasive clinical 
diagnosis is currently difficult, but a reliable, efficient method would deliver more 
accurate and earlier initial diagnoses. Currently, there is no standardized approach to the 
physical exam that allows identification of pelvic pain patients most at-risk for 
endometriosis. Examination of both external genitalia as well phenotypic findings on the 
internal exam are focused on nodularity, visible lesions, or masses, not tenderness (Riazi 
et al., 2015). By focusing future research on pain, instead of lesions, the underlying 





Due to the state demographics of Michigan, the participant population was 
predominantly caucasian. Prior studies have provided conflicting evidence regarding the 
effects of race and ethnicity on the prevalence of endometriosis, so a more diverse sample 
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size would provide more evidence on the matter. It has been reported that endometriosis 
does not vary based on ethnicity (Bulletti et al., 2010). Other studies have reported that 
the risk of the disease is increased in patients of Asian descent (Riazi et al., 2015). A 
larger sample size would have allowed more sophisticated models of statistical analysis. 
For example, Generalized Linear Models allows the analysis of interaction effects and 
predictors, but a larger participant population would be needed to utilize these analyses. 
Missing data on the physical exam, predominantly for the CPP Ø Endo group, 
contributed to the smaller sample size. Participant group sizes were slightly unbalanced 
based on exclusionary criteria during the recruitment process.  
Another limitation of this study is the potential inclusion of asymptomatic 
endometriosis patients in the “healthy-control” participant group. Healthy controls were 
recruited based on age and lack of pain, but did not undergo surgery to rule-out the 
possibility of pain-free endometriosis. Although it is unlikely that any of the controls 
consisted of this small asymptomatic population, at most this would have affected 2 
controls (2-9%) (As-Sanie et al., 2013).  
The absence of a validated protocol for assessing internal tenderpoints creates 
another study limitation. Although a thorough physical examination, including an internal 
bimanual exam and external assessment, was completed in order to identify these regions, 
it was the first of its kind with no previous clinical foundation. For the purposes of this 
study, a standardized case report was developed. All pelvic exams were performed by a 
single physician, providing as much standardization and consistency as possible 
throughout the study. Without a previously validated case report, the reliability of the 
	
47 
physical exam methodology was based on the expertise of the experimenter. 
Additionally, pelvic examinations were not performed on healthy controls. Although the 
protocol of this study allowed for comparison between the gynecological sample, none of 
the physical exam findings were compared to non-patient scores. Future research 
including all participant groups in the physical exam component of the study would 
provide stronger evidence of abnormal pelvic exam findings in the endometriosis and 
CPP populations.   
The method of QST used in this study did not allow specific identification of the 
underlying CNS mechanism responsible for the central sensitization found in chronic 
pain patients. Brain imaging was not utilized in this study, but previous research has 
provided evidence that women with pain-free endometriosis have increased gray matter 
in the antinociceptive pain regulatory system. This volume increase in the 
periaqueductual gray was not identified in women with chronic pelvic pain (As-Sanie et 
al., 2012).  
 
Future Directions  
 
As the first study to integrate a bimanual pelvic exam with quantitative sensory 
testing, there are various applications, both clinical and research-based, that can be 
applied to the future of gynecology. Recently, the Michigan Body Map (MBM) has been 
developed as a standardized self-report measure used to assess areas of chronic pain 
(Brummett et al., 2016). Patients are given a body map figure (Figure 5) and asked to 
check off regions of the body in which they have experienced persistent or recurrent 
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chronic pain (> 3 months). Those without chronic pain indicate “No chronic pain” on the 
MBM. While this measure has often been utilized for diagnosing fibromyalgia, the MBM 
can also assess centralized pain resulting from other etiologies. Developed by the 
University of Michigan Medical School, this protocol is reliable, valid, and accurate; P= 
0.013 (Brummett et al., 2016). The findings of this study suggest that internal tenderness 
is another identifier of centralized pain. The introduction of an internal tenderpoint to the 
MBM could create a more comprehensive assessment of central pain amplification.  
  
Figure 5: Michigan Body Map  
Brummett, C. M., Bakshi, R. R., Goesling, J., Leung, D., Moser, S. E., Zollars, J. W., … Hassett, A. L. 
(2016). Preliminary validation of the Michigan Body Map. Pain, 157(6), 1205–1212. 
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This study utilized pressure-pain QST protocols to assess central sensitization. 
Our results suggest that patients diagnosed with chronic pain conditions have lower 
pressure-pain thresholds, indicating greater amplification of the central nervous system. It 
would be beneficial to continue QST assessments on patients with chronic pain, 
incorporating more methods of testing, in addition to the use of a pressure algometer. 
QST methods include thermal and mechanical detection and pain thresholds (Cornelissen 
et al., 2014). Other modalities of QST, aside from pressure pain thresholds, could be 
implemented in future work, such as staircase thermal testing.  
Currently, most endometriosis research is aimed at the presence and severity of 
endometrial lesions outside of the uterus. It has been well-established that chronic pain is 
associated with the disease, although the underlying mechanism responsible for this pain 
is poorly understood. Future research focused on the role of the CNS in endometriosis 
and CPP could advance our understanding of chronic pain syndromes. Neuroimaging and 
genetic biomarker exploration could provide tangible evidence for a shared underlying 
pain mechanism among CPS. Sensory neurons are key players in wound healing, a 
component of chronic illness that could explain the centralized aspect of pain 
amplification (Lolignier et al., 2015).   
Future research should also be aimed at minimizing the invasive nature of 
endometriosis diagnosis. The potential use of circulating endometrial cells as a biomarker 
for endometriosis, in addition to a thorough pelvic exam, could reduce unnecessary 
laparoscopic surgeries. Furthermore, the addition of an internal tenderpoint to the MBM 
could further identify high-risk patients. As a result, only those patients most at risk for 
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endometriosis would need to sustain exploratory surgical diagnosis. Although 
laparoscopic investigation is currently the golden standard of diagnosis, endometriosis 
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